MedTrace Logo

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

NCT05423431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2022-06-24

No results posted yet for this study

Summary

Dosimetry efficacy of the hydrogel spacer.

Conditions

Interventions

OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with a hydrogel spacer.

Sponsors & Collaborators

  • BioProtect

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-09
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05423431 on ClinicalTrials.gov